Zobrazeno 1 - 10 of 17 pro vyhledávání: '"Paul C Kruger"'
1
How can the results of the COMPASS trial benefit patients with coronary or peripheral artery disease in Poland?
Autor: Paul C Kruger, John W. Eikelboom, Tomasz J. Guzik
Publikováno v: Kardiologia Polska. 77:661-669
Aspirin decreases the risk of recurrent thrombotic events in patients with coronary artery disease or peripheral artery disease but the risk of recurrent events remains high. Long‑term dual antiplatelet therapy or the combination of aspirin and war
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1f86c55a13c5c6e94524e66f32e1684
https://doi.org/10.33963/kp.14855
Zobrazit plný text záznamu
2
Pulmonary embolism: update on diagnosis and management
Autor: James D. Douketis, John Eikelboom, Graeme J. Hankey, Paul C Kruger
Publikováno v: Medical Journal of Australia. 211:82-87
Pulmonary embolism (PE) is a potentially life-threatening condition, mandating urgent diagnosis and treatment. The symptoms of PE may be non-specific; diagnosis therefore relies on a clinical assessment and objective diagnostic testing. A clinical de
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44fabeff111cc9a54dfaf4a4fbd02781
https://doi.org/10.5694/mja2.50233
Zobrazit plný text záznamu
3
Deep vein thrombosis: update on diagnosis and management
Autor: Paul C Kruger, James D. Douketis, John Eikelboom, Graeme J. Hankey
Publikováno v: Medical Journal of Australia. 210:516-524
Diagnosis of deep vein thrombosis (DVT) requires a multifaceted approach that includes clinical assessment, evaluation of pre-test probability, and objective diagnostic testing. Common symptoms and signs of DVT are pain, swelling, erythema and dilate
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d7086a8bb95764e297fde64452dcf0b
https://doi.org/10.5694/mja2.50201
Zobrazit plný text záznamu
4
Apixaban for Stroke Prevention in Atrial Fibrillation: Why are Event Rates Higher in Clinical Practice than in Randomized Trials?-A Systematic Review
Autor: Tim A. C. de Vries, Jeffrey S. Ginsberg, Imaad Mallick, Noel C. Chan, John W. Eikelboom, Paul C Kruger, Vinai Bhagirath, Jack Hirsh, Ke Xu
Publikováno v: Thrombosis and haemostasis. 120(9)
Background Recent reports suggest an important contribution from frequent off-label use of apixaban 2.5 mg twice daily to the higher rates of thromboembolic events observed in observational studies (OSs) relative to in randomized controlled trials (R
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51631b0d9e2487a4276110f2563adac2
https://pubmed.ncbi.nlm.nih.gov/32668484
Zobrazit plný text záznamu
5
In Vitro Reversal of the Anti-Aggregant Effect of Ticagrelor Using Untreated Platelets
Autor: Jeffrey S. Ginsberg, Vinai Bhagirath, Tim A. C. de Vries, John W. Eikelboom, Ke Xu, Noel C. Chan, Paul C Kruger, Brian Dale, Jack Hirsh
Publikováno v: Thrombosis and Haemostasis. 118:1895-1901
Background Ticagrelor is an anti-platelet agent that is indicated for prevention of thrombosis after acute coronary syndrome or intra-coronary artery stent implantation, but it increases the risk of bleeding. Platelet transfusion has the potential to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2a95f03658e1ff918e9548f6a527ee9
https://doi.org/10.1055/s-0038-1673381
Zobrazit plný text záznamu
7
Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada
Autor: Jack Hirsh, Paul C Kruger, Jackie Bosch, John W. Eikelboom, Jeffrey S. Ginsberg, Vinai Bhagirath, Sarah R Monagle
Publikováno v: Journal of Thrombosis and Thrombolysis. 46:310-315
Canadian guidelines recommend non vitamin K antagonists (NOACs) in preference to vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation (AF), but NOACs are more expensive than VKAs. Canada has a universal healthcare s
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dba790433be53465e49d39107383e759
https://doi.org/10.1007/s11239-018-1692-4
Zobrazit plný text záznamu
8
Reduction in Mortality following Elective Major Hip and Knee Surgery: A Systematic Review and Meta-Analysis
Autor: John W. Eikelboom, Smita Sinha, Jeffrey S. Ginsberg, Shrikant I. Bangdiwala, Paul C Kruger, Gordon H. Guyatt, Jack Hirsh, Vinai Bhagirath, Quazi Ibrahim, Noel C. Chan, Ke Xu
Publikováno v: Thrombosis and haemostasis. 119(4)
Background Systematic reviews reporting time trends in mortality following major orthopaedic surgery are few and have limitations. They reported on only a fraction (< 15%) of the available data and did not investigate potential causes of the reductio
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f296938f0b2f47e6f1a336f6309367cf
https://pubmed.ncbi.nlm.nih.gov/30699447
Zobrazit plný text záznamu
9
Quantifying immature platelets as markers of increased platelet production after coronary artery bypass grafting surgery
Autor: Richard P. Whitlock, Brian Dale, Jeffrey S. Ginsberg, Chunjian Li, Paul C Kruger, Jack Hirsh, Ke Xu, Noel C. Chan, Mark Crowther, John W. Eikelboom, Vinai Bhagirath
Publikováno v: European journal of haematology. 101(3)
Objectives: An increased rate of platelet production is a possible cause of reduced antithrombotic response to once-daily aspirin. Markers of immature platelets (IPs),such as immature platelet count (IPC), immature platelet fraction (IPF), and mean p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be85848781901dd8ce4a5ab7e3aa5cd5
https://pubmed.ncbi.nlm.nih.gov/29893420
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje